Shorts

Nocturia in older adults: Understanding its clinical significance

The case for permanent Medicare payment reform in urology

The UroOnc Minute: Emphasizing cribriform and IDC reporting in prostate cancer

The Expert APProach: Leveraging coding to demonstrate APP productivity and value

Hans Arora, MD, PhD, discusses the role of APPs and nurses in surgical care

Early diagnosis and guideline-concordant penile cancer care

IVF-related incontinence: When to reassure vs refer

Adjuvant pembrolizumab in RCC: Counseling patients on long-term toxicity

Testosterone therapy in women: Rethinking pre- and postmenopausal categories

IVF and voiding symptoms: Start with cycle timing

The UroOnc Minute: The importance of BCG maintenance in NMIBC

Keith Xavier, MD, URPS, shares early experience with Altaviva for male urge incontinence

Adam B. Murphy, MD, MBA, MSCI, urges thoughtful AI integration to prevent clinician burnout

Joshua Lang, MD, MS, on matching treatment intensity to tumor biology

Joshua Halpern, MD, on the advantages of mail-in semen analysis

EV/pembro approval: Translating the science into global care

Janelle Bunce, PA-C, discusses a holistic approach to testosterone deficiency care

Matthew Galsky, MD, on the changing role of cisplatin eligibility in MIBC

Joshua Halpern, MD, on what’s next in male fertility diagnostics

EV/pembro toxicity: What patients need to know upfront

The UroOnc Minute: Using physician data to improve patient outcomes

Debra L. Fromer, MD, highlights efficacy data on tebipenem pivoxil for cUTI

Beyond trial and error: The future of functional urology

How the BRIDGE trial may impact bladder cancer treatment

A new perioperative standard emerges for MIBC

Matthew Galsky, MD, explains the significance of perioperative EV/pembro in MIBC

From symptoms to systems: How functional urology evolved

First Assist: The evolving role of cystectomy in bladder cancer

Closing the gap: Urologists and female sexual health

Testosterone and prostate cancer risk: A balanced message